Literature DB >> 15293968

Kaposis sarcoma in a Nairobi hospital.

J F Onyango1, A Njiru.   

Abstract

BACKGROUND: Kaposi's sarcoma (KS) is associated epidemiologically with HIV infection and a number of countries have reported a dramatic increase in the incidence of KS with the advent of AIDS. Although AIDS is prevalent in Kenya, no studies on the impact of AIDS on the pattern of KS has been carried out.
OBJECTIVE: To determine any changes in the pattern of KS that might have occurred since the advent of AIDS in the country.
DESIGN: Retrospective descriptive study.
SETTING: Kenyatta National Hospital (KNH).
METHOD: Pathology records of cases of KS diagnosed at KNH from 1968 to 1997 were analysed with respect to relative frequency, age, sex and site distribution; and trend. The period was divided into the pre and post AIDS era from 1983, which is the time the first AIDS patient was reported in the country. RESULT: A total of 1108 cases of KS consisting of 911 males and 197 females were recorded. The relative frequency of KS ranged between 2% to 5% of the total malignancies. There was a gradual decline in the male to female ratio from about 10:1 in the sixties to about 2:1 in 1997. There was no dramatic difference in the age distribution in the pre and post AIDS era, although a large number of cases were recorded as adults without age specification in the post AIDS era. Site distribution was characteristic of the disease with most of the cases having the lesions occurring in the lower limbs and involving the skin.
CONCLUSION: Although these findings do not demonstrate a dramatic alteration in the pattern of KS in the post AIDS era there were indications that such changes may have been obscured by under-reporting. The fall in the male:female ratio is a strong indication of a rise in KS among female patients. A further study is necessary to elucidate the true impact of AIDS on the pattern of KS in the country.

Entities:  

Mesh:

Year:  2004        PMID: 15293968     DOI: 10.4314/eamj.v81i3.9139

Source DB:  PubMed          Journal:  East Afr Med J        ISSN: 0012-835X


  7 in total

1.  Kaposi sarcoma in calabar, southern Nigeria.

Authors:  Maurice Asuquo; Aniefon Umana; Otei Otei; Imabasi Bassey; Godwin Ebughe
Journal:  Oman Med J       Date:  2009-01

2.  Kaposi's sarcoma: a 10-year experience with 248 patients at a single tertiary care hospital in Tanzania.

Authors:  Phillipo L Chalya; Fidelis Mbunda; Peter F Rambau; Hyasinta Jaka; Nestory Masalu; Mariam Mirambo; Martha F Mushi; Samuel E Kalluvya
Journal:  BMC Res Notes       Date:  2015-09-15

3.  Gender differences in clinical presentation and outcomes of epidemic Kaposi sarcoma in Uganda.

Authors:  Warren Phipps; Fred Ssewankambo; Huong Nguyen; Misty Saracino; Anna Wald; Lawrence Corey; Jackson Orem; Andrew Kambugu; Corey Casper
Journal:  PLoS One       Date:  2010-11-12       Impact factor: 3.240

4.  Human herpesvirus-8 (HHV-8) sero-detection and HIV association in Kaposi's sarcoma (KS), non-KS tumors and non-neoplastic conditions.

Authors:  Amos R Mwakigonja; Pawan Pyakurel; Parviz Kokhaei; Fatemeh Pak; Leonard K Lema; Ephata E Kaaya; Peter Biberfeld
Journal:  Infect Agent Cancer       Date:  2008-06-30       Impact factor: 2.965

5.  Trends in prevalence of diarrhoea, Kaposi's sarcoma, bacterial pneumonia, malaria and geohelminths among HIV positive individuals in Uganda.

Authors:  John Rubaihayo; Nazarius M Tumwesigye; Joseph Konde-Lule
Journal:  AIDS Res Ther       Date:  2015-06-13       Impact factor: 2.250

6.  Selected genes of Human herpesvirus-8 associated Kaposi's sarcoma among patients with Human Immunodeficiency Virus-1 and Acquired Immunodeficiency Disease Syndrome.

Authors:  Rodgers Norman Demba; Nathan Shaviya; Sylviah Mweyeli Aradi; Walter Mwanda
Journal:  Pan Afr Med J       Date:  2019-04-30

7.  Three year survival among patients with aids-related Kaposi sarcoma treated with chemotherapy and combination antiretroviral therapy at Moi teaching and referral hospital, Kenya.

Authors:  Naftali Busakhala; Gabriel Kigen; Paul Waako; R Matthew Strother; Fredrick Chite; Patrick Loehrer
Journal:  Infect Agent Cancer       Date:  2019-09-10       Impact factor: 2.965

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.